L-OHP is a useful medicine in tumour chemotherapy, so we wonder whether the reduced autophagy by ASPP2 is associated with cell death especially in p53 inactivation situation, which is common in clinical colon cancer. Here, TP53BP2 is linked to malignant colon neoplasm.